Valuation: Integer Holdings Corp

Market Cap 4.29B 3.73B 3.53B 3.21B 6B 411B 6.03B 42.09B 16.28B 209B 16.1B 15.75B 668B P/E 2026 *
41.4x
P/E 2027 * 27.2x
Enterprise Value 4.29B 3.73B 3.53B 3.21B 6B 411B 6.03B 42.09B 16.28B 209B 16.1B 15.75B 668B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.22x
Free-Float
94.46%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-10-23
Director of Finance/CFO 53 2023-05-07
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Director/Board Member 67 2015-07-01
Director/Board Member 68 2015-07-01
Chairman 72 2026-05-19
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%+9.14%+39.29%+29.66% 240B
+1.99%+5.97%+10.14%-16.26% 146B
+0.33%+6.40%-11.56%+28.63% 135B
-0.82%+1.04%-55.79%-17.83% 63.64B
+0.16%-0.70%-19.34%-16.71% 49.27B
-1.15%+1.71%+17.35%+20.99% 51.46B
+1.72%+9.24%+23.37%+38.73% 43.33B
+2.65%+6.99%+41.50%+57.18% 41.13B
+7.10%+21.82%+143.07%+72.16% 34.57B
Average +1.65%+3.16%+20.89%+21.84% 89.41B
Weighted average by Cap. +1.37%+4.32%+16.65%+17.70%

Financials

2026 *2027 *
Net sales 1.82B 1.59B 1.5B 1.36B 2.55B 174B 2.56B 17.88B 6.91B 88.62B 6.84B 6.69B 284B 1.93B 1.68B 1.59B 1.44B 2.7B 185B 2.71B 18.94B 7.32B 93.9B 7.25B 7.09B 301B
Net income 110M 96.24M 91.09M 82.76M 155M 10.58B 155M 1.08B 420M 5.38B 415M 406M 17.22B 158M 138M 130M 118M 221M 15.14B 222M 1.55B 600M 7.69B 594M 581M 24.63B
Net Debt - -
Logo Integer Holdings Corp
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!